14-day Premium Trial Subscription Sign Up For FreeGet Free

DBV Technologies S.A. Stock Forecast NASDAQ:DBVT

Price Target and Analyst Ratings

Most Recent Rating

On September 14, 2021 "Societe Generale" gave "" rating for DBVT. The price target was changed from $4.84 to 3.8%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-14 Upgraded by Societe Generale $4.94 $4.84→3.8%
2021-05-04 Sell - Hold Upgraded by Societe Generale $6.51
2021-05-03 Sell - Buy Upgraded by Bryan, Garnier & Co $6.15
2021-03-12 Outperform Reiterated by SVB Leerink $5.99
2021-01-22 Hold - Sell Downgraded by Societe Generale $5.93
2021-01-18 Target Raised by The Goldman Sachs Group $5.66 $4.00 → $7.00
2021-01-15 Target Raised by Citigroup $5.66 $4.00 → $8.00
2020-11-02 Sell - Hold Upgraded by Societe Generale $1.76
2020-08-11 Hold Reiterated by Jefferies Financial Group $2.30 $2.50
2020-08-06 Buy - Sell Downgraded by Societe Generale $2.32
2020-08-05 Buy Target Lowered by HC Wainwright $2.48 $25.00 → $14.00
2020-08-05 Buy Target Lowered by Citigroup $2.48 $10.00 → $4.00
2020-08-05 Equal Weight Target Lowered by Morgan Stanley $2.48 $4.00 → $2.00
2020-08-04 Neutral - Sell Downgraded by Bryan, Garnier & Co $2.34
2020-07-02 Buy Initiated by JMP Securities $4.47 $10.00
2020-06-26 Hold Reiterated by Stifel Nicolaus $4.66

DBVT Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -7.48% during the next 3 months and, with a 90% probability hold a price between $4.14 and $5.39 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-22 $4.47 $5.14 $5.82
2021-09-23 $4.46 $5.14 $5.81
2021-09-24 $4.46 $5.13 $5.80
2021-09-27 $4.45 $5.12 $5.79
2021-09-28 $4.44 $5.11 $5.79
2021-09-29 $4.43 $5.11 $5.78
2021-09-30 $4.43 $5.10 $5.77
2021-10-01 $4.42 $5.09 $5.76
2021-10-04 $4.41 $5.08 $5.76
2021-10-05 $4.40 $5.08 $5.75
2021-10-06 $4.40 $5.07 $5.74
2021-10-07 $4.39 $5.06 $5.73
2021-10-08 $4.38 $5.05 $5.73
2021-10-11 $4.37 $5.05 $5.72
2021-10-12 $4.37 $5.04 $5.71
2021-10-13 $4.36 $5.03 $5.70
2021-10-14 $4.35 $5.02 $5.70
2021-10-15 $4.34 $5.02 $5.69
2021-10-18 $4.34 $5.01 $5.68
2021-10-19 $4.33 $5.00 $5.67
2021-10-20 $4.32 $4.99 $5.67
2021-10-21 $4.31 $4.99 $5.66
2021-10-22 $4.31 $4.98 $5.65
2021-10-25 $4.30 $4.97 $5.64
2021-10-26 $4.29 $4.96 $5.64
2021-10-27 $4.28 $4.96 $5.63
2021-10-28 $4.28 $4.95 $5.62
2021-10-29 $4.27 $4.94 $5.61
2021-11-01 $4.26 $4.93 $5.61
2021-11-02 $4.25 $4.93 $5.60

About DBV Technologies S.A.

DBV Technologies SA DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product which is in Phase III clinical trials for the treatment of peanut allergies in children, adolescents, and adults. The company is also developing Viaskin Milk that is in Phase II clinical trials for the treatment of CMPA and milk-ind... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT